Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services for $45m
Fortrea has agreed to acquire Worldwide Clinical Trials' clinical pharmacology unit and bioanalytical laboratory operations for about $45m in cash, comprising a GLP bioanalytical laboratory in Austin, a 200-bed clinical pharmacology unit in San Antonio and a biospecimen storage site in Pflugerville, all in Texas. Worldwide says the sale will let it focus investment on its late-stage business in oncology, neuroscience, internal medicine and rare disease, and completion remains subject to regulatory and licence approvals.